Bruce Downey
Chairman bij C4 THERAPEUTICS, INC.
Vermogen: 10 M $ op 31-03-2024
Profiel
Bruce L. Downey is partner bij NewSpring Health Capital II LP en partner bij NSV II Management Co. LLC en zit in de raad van bestuur van 5 andere bedrijven. In het verleden was hij Partner bij Winston & Strawn LLP, Partner bij Bishop, Cook, Purcell & Reynolds, Voorzitter & Chief Executive Officer van Barr Pharmaceuticals, Inc., Voorzitter van Momenta Pharmaceuticals, Inc., Principal bij US Department of Justice en Voorzitter bij Association for Accessible Medicines. Bruce L. Downey is afgestudeerd aan de Ohio State University en behaalde een doctoraal aan de Miami University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
CARDINAL HEALTH, INC.
0.02% | 18-09-2023 | 52 729 ( 0.02% ) | 6 M $ | 31-03-2024 |
C4 THERAPEUTICS, INC.
0.71% | 15-06-2023 | 489 542 ( 0.71% ) | 4 M $ | 31-03-2024 |
Actieve functies van Bruce Downey
Bedrijven | Functie | Begin |
---|---|---|
C4 THERAPEUTICS, INC. | Chairman | 01-06-2022 |
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Director/Board Member | 01-04-2011 |
NSV II Management Co. LLC
NSV II Management Co. LLC Investment ManagersFinance NSV II Management Co. LLC provides investment management services. It is a private equity and venture capital firm specializing in investing in growth capital, growth and expansion stage, recapitalization, mid stage, late stage, mezzanine, control buyouts, mergers and acquisitions and management buyouts in middle market companies. The company was founded by Michael A. DiPiano and Marc R. Lederman in 1999 and is headquartered in Radnor, PA. | Corporate Officer/Principal | 01-04-2009 |
NewSpring Health Capital II LP
NewSpring Health Capital II LP Investment ManagersFinance NewSpring Health Capital II LP invests in companies located in the United States, primarily in the Mid-Atlantic region. The fund targets companies operating in the fields of pharmaceuticals, medical technologies and healthcare services. It acts as lead investor and provides financing for recapitalizations, buyouts, mergers & acquisitions and growth capital requirements with an investment size ranging from $2 to $5 million per company. It makes follow-on investments and also considers co-investments. | Corporate Officer/Principal | 01-04-2009 |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Director/Board Member | - |
Putney, Inc.
Putney, Inc. Pharmaceuticals: MajorHealth Technology Putney, Inc. operates as a veterinary pharmaceutical company which specializes in the development of generic medicine for pets. It offers human-approved generic drugs such as ampicillin sodium for injection, cefpodoxime proxetil tablets and amoxicillin trihydrate capsules. The firm also provides injectables, carprofen caplets and dermatological therapeutics. The company was founded by Jean Hoffman in 2006 and is headquartered in Portland, ME. | Director/Board Member | - |
NewSpring Healthcare
NewSpring Healthcare Investment ManagersFinance NewSpring Healthcare is the venture capital/private equity operating health care division of NewSpring Capital LLC founded in 1999. The firm is headquartered in Radnor, Pennsylvania. | Private Equity Investor | 01-04-2009 |
Eerdere bekende functies van Bruce Downey
Bedrijven | Functie | Einde |
---|---|---|
CARDINAL HEALTH, INC. | Director/Board Member | 15-11-2023 |
MOMENTA PHARMACEUTICALS, INC. | Chairman | 01-10-2020 |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░ | - |
Opleiding van Bruce Downey
Miami University | Undergraduate Degree |
The Ohio State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
CARDINAL HEALTH, INC. | Distribution Services |
C4 THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 14 |
---|---|
Barr Pharmaceuticals, Inc.
Barr Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Barr Pharmaceuticals, Inc. manufactures and sells generic prescription pharmaceutical products. The company was founded in 1970 and is headquartered in Montvale, NJ. | Health Technology |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Putney, Inc.
Putney, Inc. Pharmaceuticals: MajorHealth Technology Putney, Inc. operates as a veterinary pharmaceutical company which specializes in the development of generic medicine for pets. It offers human-approved generic drugs such as ampicillin sodium for injection, cefpodoxime proxetil tablets and amoxicillin trihydrate capsules. The firm also provides injectables, carprofen caplets and dermatological therapeutics. The company was founded by Jean Hoffman in 2006 and is headquartered in Portland, ME. | Health Technology |
NewSpring Health Capital II LP
NewSpring Health Capital II LP Investment ManagersFinance NewSpring Health Capital II LP invests in companies located in the United States, primarily in the Mid-Atlantic region. The fund targets companies operating in the fields of pharmaceuticals, medical technologies and healthcare services. It acts as lead investor and provides financing for recapitalizations, buyouts, mergers & acquisitions and growth capital requirements with an investment size ranging from $2 to $5 million per company. It makes follow-on investments and also considers co-investments. | Finance |
OncoPep, Inc.
OncoPep, Inc. Investment ManagersFinance OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company?s product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA. | Finance |
Winston & Strawn LLP
Winston & Strawn LLP Miscellaneous Commercial ServicesCommercial Services Winston & Strawn LLP provides legal services. Its service areas include antitrust & trade regulations, employment & labor relations, intellectual property, taxation & trusts, and estates to automotive, aviation, electric power, financial services, and health care. The company was founded by Frederick H. Winston in 1853 and is headquartered in Chicago, IL. | Commercial Services |
NSV II Management Co. LLC
NSV II Management Co. LLC Investment ManagersFinance NSV II Management Co. LLC provides investment management services. It is a private equity and venture capital firm specializing in investing in growth capital, growth and expansion stage, recapitalization, mid stage, late stage, mezzanine, control buyouts, mergers and acquisitions and management buyouts in middle market companies. The company was founded by Michael A. DiPiano and Marc R. Lederman in 1999 and is headquartered in Radnor, PA. | Finance |
US Department of Justice | Government |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
Bishop, Cook, Purcell & Reynolds | |
NewSpring Healthcare
NewSpring Healthcare Investment ManagersFinance NewSpring Healthcare is the venture capital/private equity operating health care division of NewSpring Capital LLC founded in 1999. The firm is headquartered in Radnor, Pennsylvania. | Finance |
Acetylon Pharmaceuticals, Inc.
Acetylon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Acetylon Pharmaceuticals, Inc. develops pharmaceutical technology. It develops novel small molecule drugs which targets epigenetic mechanisms for the enhancement of therapeutic outcomes in cancer and other critical human diseases. The company was founded by Ralph Mazitschek, Kenneth C. Anderson, Marc A. Cohen, James E. Bradner, and Walter C. Ogier in October 2008 and is headquartered in Boston, MA. | Health Technology |
Melinta Therapeutics, Inc.
Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
Warner Chilcott Pharmaceuticals, Inc.
Warner Chilcott Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Warner Chilcott Pharmaceuticals, Inc. is a private company based in Mason. | Health Technology |